Table 3. Outcome according to MSKCC prognostic group for patients who received only TTs and for those who received pancreatic local treatment (surgery or local radiation therapy).
| MSKCC prognostic group | n | % | Median OS (months) | 95% CI (range)(months) | 5-year OS (%) | p |
|---|---|---|---|---|---|---|
| Patients receiving TTs | 0.255 | |||||
| Good | 63 | 36 | 46 | (37–107) | 34.7 | |
| Intermediate | 97 | 55 | 55 | (45–70) | 49.4 | |
| Poor | 16 | 9 | 61 | (2–70) | 51.4 | |
| Patients who received pancreatic local treatment | 0.377 | |||||
| Good | 33 | 51 | 83 | (65-NA) | 88.2 | |
| Intermediate | 31 | 48 | 106 | (29–171) | 66.1 | |
| Poor | 1 | 1 | - | - | - |